Assembly Biosciences Inc
NASDAQ:ASMB 12:27:02 PM EDT
| Market Cap (Intraday) | 157.82M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $4.03 |
| 50-Day MA | $4.43 |
| 200-Day MA | $9.90 |
Assembly Biosciences Inc Stock, NASDAQ:ASMB
331 Oyster Point Boulevard, 4th floor, South San Francisco, California 94080
United States of America
Phone: +1.833.509.4583
Number of Employees: 139
Description
Assembly Biosciences, Inc. is a biotechnology company, which engages in the development of products for infectious diseases, such as chronic hepatitis B virus and illnesses associated with a dysbiotic microbiome. It focuses in two innovative platform programs: oral therapeutics for the treatment of hepatitis B virus, and the oral synthetic live biotherapeutics candidate. The company was founded by Uri Lopatin and Derek A. Small on October 7, 2005 and is headquartered in South San Francisco, CA.